Ebos Group stock holds steady as FY26 guidance brackets consensus
Published on 08/31/2026 at 07:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ebos Group Ltd. (ISIN NZEBOE0001S6) stock traded close to its recent level on the latest session as investors weighed FY26 results and fresh FY27 guidance that broadly align with market forecasts as of August 31, 2026.
Per a Corporate Results Monitor snapshot dated August 31, 2026, Ebos Group reported FY26 performance that was in line with expectations, supported by solid Healthcare operations and strong Animal Care growth heading into FY27.
FY26 results in line with expectations
According to the Corporate Results Monitor entry for EBO published on August 31, 2026, FY26 earnings were described as broadly in line with consensus, with the company completing a major distribution center renewal program ahead of the new financial year.
In the same overview, the commentary notes that Ebos Group exits FY26 with scope for stronger cash flow and improving returns, underpinned by the now-completed renewal of a key distribution facility and the combination of solid Healthcare performance and strong Animal Care growth.
FY27 guidance and contract headwinds
The Corporate Results Monitor entry states that FY27 EBITDA guidance for Ebos Group brackets consensus, indicating that management targets sit within the range of market expectations rather than signaling a sharp deviation from analyst forecasts.
The same report highlights that while Animal Care is expected to continue growing strongly and Healthcare remains solid, there are lingering earnings headwinds linked to the loss of the Chemist Warehouse New Zealand contract that may temper near-term EBITDA progression in FY27.
Representative product: healthcare distribution
A core element of Ebos Group's business model is large-scale healthcare distribution, supplying pharmaceuticals and medical products from manufacturers to pharmacies, hospitals, and other care providers across its operating regions.
Stock level and investor view
Market data from an Australia share market overview shows EBO last traded at AUD 17.73, with an intraday high of AUD 17.90 and a low of AUD 17.45, and a session change of AUD 0.05, equivalent to a 0.28 percent gain, on volume of 99,420 shares as of August 30, 2026.
Read more
More on Ebos Group stock: Investor Relations
Fact box
Company: Ebos Group Ltd.
ISIN: NZEBOE0001S6
Ticker: EBO
Exchange: Australia (primary listing)
Price (as of August 30, 2026): AUD 17.73
Sector / Industry: Healthcare distribution and animal care
